PhenomeX (NASDAQ: BLI)
Some price data may be temporarily unavailable.
PhenomeX Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
PhenomeX Company Info
Develops and commercializes platforms for bio-pharmaceutical, genomic and cellular therapy applications
News & Analysis
Featured Article
Why Berkeley Lights Stock Went Dark on Thursday
Investors were spooked by several numbers in the company's latest business update.
Eric Volkman | Jan 6, 2022
Featured Article
Why Berkeley Lights Fell Again Today, Despite Bullish New Analyst Notes
A short seller's stinging Twitter diatribe against the company continues to affect investor sentiment.
Eric Volkman | Sep 16, 2021
Valuation
Earnings Transcripts
Berkeley Lights, Inc. (BLI) Q2 2022 Earnings Call Transcript
BLI earnings call for the period ending June 30, 2022.
Motley Fool Transcribing | Aug 10, 2022
Berkeley Lights, Inc. (BLI) Q1 2022 Earnings Call Transcript
BLI earnings call for the period ending March 31, 2022.
Motley Fool Transcribing | May 10, 2022
Berkeley Lights, Inc. (BLI) Q4 2021 Earnings Call Transcript
BLI earnings call for the period ending December 31, 2021.
Motley Fool Transcribing | Feb 25, 2022
Berkeley Lights, Inc. (BLI) Q3 2021 Earnings Call Transcript
BLI earnings call for the period ending September 30, 2021.
Motley Fool Transcribing | Nov 5, 2021
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.